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Abstract 
Background: To perform a retrospective analysis of patients who underwent endoscopic 
atraumatic coronary artery off-pump bypass grafting (EACAB) in a single center over a 
period of 11 years. 
Methods: Data was acquired from the hospital registry and patient medical records. In 
order to determine changes in clinical profile, patients were subdivided into three groups 
regarding year of surgery: 1998–2002 (group 1), 2003–2005 (group 2), 2006-2009 (group 
3). In-hospital analysis up to 30 days and long-term observation were conducted. 
Results: The study cohort consisted of 714 patients (581 male). Procedural success 
accounted for 99% of all patients. No mortality was observed up to 30 days. Complications 
in the early period included pleural effusion (7.6%), cardiac arrhythmias (3.6%), bleeding 
related revision (2.7%) and wound infection (1.6%). Mean follow-up was 6 years (2132 ± 
1313 days; Mdn: 1918.5). Nineteen (2.7%) patients died, of which 52.6% (10 patients) 
were due to heart related conditions. Overall frequency of major adverse cerebral and 
cardio-vascular events (MACCE) was 10.8% (77 patients). The Kaplan-Meyer analysis 
defined survival rate and event-free survival in long-term observation of 96.1% and 85.3%, 
respectively. Ejection fraction (EF) < 50% was the only independent factor of mortality 
(OR: 3.35). Regarding cumulative MACCE, older age (OR: 1.72), lower EF (OR: 3.03), the 
history of percutaneous coronary intervention (OR: 2.13) and higher New York Heart 
Association class (OR: 2.63) influenced the incidence rate. 
Conclusions: The presented short and very long-term results confirm that EACAB is an 
efficient alternative for patients requiring revascularization of the left anterior descending 
artery. The elimination of cardiopulmonary bypass significantly reduces the number of 
complications.  
Key words: endoscopic atraumatic coronary artery off-pump bypass grafting 
(EACAB), minimally invasive surgery, left anterior descending coronary artery 
stenosis, minimally invasive direct coronary artery bypass grafting (MIDCAB) 
 
 
INTRODUCTION 
Percutaneous coronary intervention (PCI) and coronary artery bypass grafting 
(CABG) are widely used revascularization techniques [1]. In a selected group of patients, 
minimally invasive direct coronary artery bypass grafting (MIDCAB) may be used as an 
alternative treatment. MIDCAB comprises high efficacy of surgical revascularization 
combined with a minimal traumatic approach due to the use of anterolateral thoracotomy or 
endoscopy (endoscopic atraumatic coronary artery bypass grafting [EACAB]) for left 
internal mammary artery (LITA) harvest and anterolateral thoracotomy for suturing the 
anastomosis. It results in the avoidance of sternotomy, reduction of wound diameter, 
improved healing and faster recovery [2, 3]. Current guidelines for the use of MIDCAB are 
limited. The procedure is most widely applied in the single vessel disease of the left 
anterior descending coronary artery (LAD), as a hybrid procedure (along with stenting of 
other vessels in patients treated for multi-vessel disease), in patients unable to undergo the 
complete CABG revascularization and as a palliative therapy in patients with in-stent 
restenosis [3, 4]. Studies have proven the efficacy and safety of the MIDCAB procedure in 
comparison to both CABG and PCI [5–8]. It is estimated that MIDCAB may be indicated 
in 2–8% of patients primarily qualified for CABG. This highlights the need for further 
investigation in order to increase usage of this method. Most available studies addressing 
MIDCAB lack long-term observation conducted on a large study cohort. Therefore,  a 
retrospective analysis was performed  on patients who underwent the procedure in the 
documented clinic over a period of 11 years. The aim was to collect for the longest possible 
follow-up and to determine changes in a surgically treated population whose characteristics 
were revealed over time. 
 
 
METHODS 
Study population 
The study cohort consisted of patients who underwent MIDCAB (EACAB) surgery 
in First Cardiac Surgery Clinic of Medical University of Silesia from April 1998 through 
December 2009. To determine the changes in clinical profiles, patients were subdivided 
into three groups depending on their year of surgery: 1998–2002 (group 1), 2003–2005 
(group 2), 2006–2009 (group 3). Retrospective analysis was performed with the use of data 
acquired from hospital registry and patient medical records. Pre-admission data, such as age, 
gender, Canadian Cardiovascular Society (CCS) class, New York Heart Association (NYHA) 
class, body mass index and others were used to calculate the additive EuroSCORE (ES) and 
logistic EuroSCORE (LES). Arrhythmias and conduction disorders were diagnosed on the 
basis of an electrocardiogram (ECG). 
 
The surgical technique 
General anesthesia was induced. The double-lumen endotracheal tube was 
introduced to ensure single lung ventilation throughout the procedure. The harmonic blade 
and endoscopic manipulators were used for the LITA harvest. When the harvest was 
completed, heparin was given in a dose adequate to the patient’s weight. The incision was 
made in the fourth or fifth intercostal space and LITA-LAD anastomosis was sutured in a 
standard technique on the beating heart, with the use of cardiac stabilizer. The protamine 
sulphate was administered after completion of the anastomosis. 
 
The primary and secondary endpoints 
The primary endpoint was major adverse cerebral and cardio-vascular event 
(MACCE) incidence throughout the observation period. The MACCE was defined as: death, 
myocardial infarction (MI), repeat cardiac revascularization (both surgical or percutaneous), 
stroke or transient ischemic attack (TIA). The secondary endpoint consisted of post-
operative renal insufficiency, hemorrhage and prolonged hospitalization. The MI was 
diagnosed in accordance to the American College of Cardiology/American Heart 
Association (ACC/AHA) guidelines, based on ECG changes, the levels of cardiac enzymes 
and the evaluation of the cardiac contractility with transthoracic (TTE) or transesophageal 
echocardiography (TEE). Neurological disorders were diagnosed with the use of imaging 
modalities (computed tomography scan) and physical examination conducted by a qualified 
neurologist. 
 
Peri-procedural observation 
In-hospital analysis consisted of peri-procedural parameters assessment, observation 
focused on both primary and secondary endpoints, as well as the incidence of other possible 
complications at the time of surgery and throughout the subsequent 30 days.  
 
Long-term observation 
Long-term observation encompassed an evaluation of post hospital mortality and 
occurrence of major adverse cerebral and cardio-vascular events (MACCE). Patients with 
incomplete in-hospital data were excluded from analysis. Follow up was gathered via 
telephone survey by qualified study coordinators. When telephone contact was not possible, 
mail was sent to the patients’ address with a request to mail back a questionnaire to be 
filled in and, if available, printed history cards from other hospitalizations. Information 
regarding mortality was confirmed owing to access to the Polish central population registry 
database called PESEL. 
 
Statistical analysis 
Statistical analysis was performed using Statistica 7.1 software by a qualified statistician. 
Differences between groups were assessed with the Student t-test and variation analysis for 
quantitative variables and with an χ2 or the Fisher test for qualitative variables. The 
cumulative survival rate was described using the Kaplan-Meier estimator plot. Factors 
influencing MACCE incidence were typed using log-rank analysis. For the proper 
interpretation of differences and correlations, statistical significance parameter was p < 0.05. 
 
 
RESULTS 
Study population 
The study cohort consisted of 714 patients (581 male, 133 female). There were 238 
patients in group 1 (33.3%), 229 patients in group 2 (32.1%) and 247 patients in group 3 
(34.6%). Detailed study cohort characterizations are shown in Table 1. The majority of 
patients presented with good left ventricular ejection fraction (LVEF) > 50% within 
average of 55%, had mild angina (CCS II: 86.1%) and preserved heart function (NYHA I: 
91.8%). Therefore, they remained in a group of low surgical risk, which was reflected both 
in additive and logistic EuroSCORE (values of ES < 3 points in 68.7% of patients and 
values of LES = 2.0 ± 1.9%).  
 
Peri-procedural observation 
Ninety-nine percent of patients successfully underwent MIDCAB (EACAB) procedure. In 
1% of cases (7 procedures) the conversion to OPCAB (4 patients) or CABG (3 patients) 
were required. Only 9.5% of surgeries were urgent (due to exacerbation of angina 
symptoms or critical LAD stenosis), the remaining were planned. All patients underwent 
LAD grafting. Most of them (99.5%) received left internal thoracic artery graft. In 0.5% of 
cases the use of LITA was impossible due to damage made to the vessel. Incomplete 
revascularization (patients requiring further percutaneous treatment) was observed in 1% of 
patients. The complete post-op drainage amounted 593.2 ± 509.5 mL on average (Mdn: 425, 
interquartile range [IQR]: 260–720). 
No deaths were observed for up to 30 days after the surgery. Complications in the 
early postoperative period were rare and included pleural effusion (7.0%), cardiac 
arrhythmias (3.6%), bleeding related revision (2.7%) and wound infection (1.6%). 
Transfusion of red cell concentrate, frozen plasma and platelet concentrate was required in 
5%, 4,7% and 0.6% of patients, respectively. The average stay in the post-operative ward 
was 2 ± 0.7 days (Mdn: 2, IQR: 2–2) with an overall hospital stay of 7 ± 1.2 days (Mdn: 7, 
IQR: 6–8). Detailed information about observed complications is listed in Table 2. 
 
Clinical profile changes 
Similar to the trend observed in cardiac surgery in general, patients undergoing the 
procedure in subsequent years were increasingly older and suffered from more concomitant 
diseases (Table 3). The reported difference in age was 3 and 6 years between groups 1 vs. 2 
and 1 vs. 3, respectively (p < 0.01). Other statistically significant differences included body 
weight (with peak value reported in group 2; p < 0.01), presence of arterial hypertension (p 
< 0.01), diabetes (p < 0.01), peptic ulcer disease (p < 0.01), past episodes of MI (p = 0.03), 
history of stroke/TIA (p = 0.02), history of PCI (p < 0.01) and renal insufficiency (p = 0.03). 
Patients qualified for the surgery were also more frequently diagnosed as having mitral (p < 
0.01) or tricuspid valve regurgitation (p < 0.04) concomitantly. What was understandable, 
all of this translated into a rise in EuroSCORE value, both additive (from 1.11 ± 1.12 in 
group 1 to 2.11 ± 1.95 in group 3) and logistic (1.12 ± 0.75 to 2.26 ± 2 24). Despite visible 
changes, this difference appeared to be statistically insignificant, reaching p = 0.06. 
Interestingly, no variations were reported in the LVEF. In following years, the median 
LVEF was stable and amounted to 55% (p = 0.13). 
The urgency of procedures evolved over time. In group 1 all patients were admitted 
for planned surgery, whereas in group 2 and 3 the amount diminished to 95.8% and 78.5%, 
respectively, giving rise to ones conducted due to urgent causes. What is more, the analysis 
of in-hospital complications showed that MI (p < 0.01) and sudden cardiac arrest (p = 0.01) 
were more likely to happen in early years. No other variations were reported in frequency 
of complications, as well as in hospital stay duration (Table 4). 
 
Long-term observation 
The average follow-up time was almost 6 years (2132 ± 1313 days; Mdn: 1918.5) 
with the longest spanning up to 13 years (4661 days). Nineteen (2.7%) patients died during 
observation period, of whom 52.6% (10 patients) due to heart related conditions. Overall 
frequency of MACCE was 10.8% (77 patients). The most frequent complication was the 
need for repeat revascularization in 50 (7%) patients with angioplasty of LIMA-LAD graft 
being responsible for 38% of cases (19/50). It was followed by MI in 2.4% (17 patients) of 
cases and stroke or TIA in 1% (7) of patients. The Kaplan-Meyer analysis defined survival 
rate and event-free survival in long-term observation of 96.1% and 85.3% respectively 
(Figs. 1, 2). Detailed analysis revealed that LVEF < 50% was the only independent factor 
of mortality (odds ratio [OR]: 3.35). Age > 57, history of PCI and higher NYHA class were 
on the edge of statistical significance. Regarding cumulative MACCE, older age (OR: 1.72), 
lower LVEF (OR: 3.03), the history of PCI (OR: 2.13) and higher NYHA class (OR: 2.63) 
influenced the incidence rate. The risk of MI rose with the presence of lower LVEF (OR: 
3.56) and incomplete revascularization (OR: 6.58), whereas risk of stroke/TIA was greater 
when the patient was over 57 years old (OR: 6.30). Other important, but not statistically 
significant, factors were the presence of arterial hypertension and male sex. Detailed 
information is shown in Table 5. 
 
DISCUSSION 
The MIDCAB surgery, along with all of its variations, is a well-established 
procedure in many cardiothoracic centers. Although PCI procedures have become 
increasingly effective over the last decades, both AHA/ACC and the European Society of 
Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) 
guidelines underline the role of surgical revascularization in patients with stable angina and 
single vessel coronary heart disease with proximal LAD stenosis (IIA/B indication in 
AHA/ACC guidelines and IA indication in ESC/EACTS guidelines) [4, 9–10]. Furthermore, 
in a recent (2017) ACC report regarding the appropriate use of revascularization criteria, 
there was no discussion about  possible changes in indications for surgical treatment in 
these cases [10].  
The main purpose of the present research was to evaluate the short and long-term 
results of minimally invasive direct coronary artery bypass performed in patients operated 
on in the documented clinic in years between 1998–2009. Moreover,  changes in the 
clinical profiles of the treated population happening over these years were analyzed.  
The research showed that clinical characteristics of patients deteriorated, making 
treatment more challenging. Simultaneously, the frequency of complications was 
significantly reduced. This potential paradox can work as a confirmation of analysis which 
is well-described in the literature, a learning curve phenomenon, and meaning reduction in 
the number of complications due to excelling of surgical techniques and operator skills. 
Research presented herein displays one of the biggest and longest observed groups 
of patients undergoing MIDCAB surgery. Mean follow-up amounted to 2132 ± 1313 days 
(Mdn: 1918.5, longest follow-up 4661 days). In the assessed time interval, frequency of 
MACCE was 10.8%, with a death rate of 2.7% and a need for revascularization of 7%. 
Bearing in mind the evaluated cumulative survival rate and event free survival of 96.9% 
and 85.3%, respectively, indicates an optimal therapeutic effect. 
As mentioned before, there are few studies regarding long-term observation after 
MIDCAB surgery. Holzhey et al. [11] reported long-term follow-up of more than 1300 
patients with a death rate of 10.6% and cumulative MACCE 16.7% in 7-year observation. 
Hoffman et al. [12] presented his observation in an octogenarian group with a median 
survival rate of 6.7 years, which correlates well with the mean survival after CABG [13, 
14] and with an age-adjusted general population. This study clearly demonstrated that the 
method provides satisfactory long-term outcomes, regardless of patient age group.  
Blazek et al. [15] compared sirolimus-eluting stenting with minimally invasive 
bypass surgery for stenosis of the LAD. Although the groups were relatively small (65 
patients each), the authors described excellent survival at median follow-up time of 7.3 
years (17% death rate in the MIDCAB group) and a clear superiority of surgical 
revascularization in terms of repeat target vessel revascularization (20% vs. 1.5%, p < 0.01). 
Similarly, Benedetto et al. [6] made a propensity score analysis of 303 MIDCAB and 730 
DES-PCI patients. They proved, that at 10 years DES-PCI was associated with a 2.19-fold 
increased risk of late death [6]. The survival rate after the MIDCAB procedure was 95.4 ± 
1.3 and 94.8 ± 1.3 at 5 and at 10 years, respectively. Deppe et al. [16] performed meta-
analysis of 2885 patients included in 12 studies. In all analyzed reports, patients were 
assigned to either PCI or MIDCAB group. The authors point out that MIDCAB reduces 
repeat target vessel revascularization of the LAD and cumulative MACCE in long-term 
observation. It is noted that the incidence of MACCEs after PCI had almost doubled for the 
entire population after 6 months, which suggests that MIDCAB is an excellent strategy 
when long-term clinical outcome is required.  
Finally, in the retrospective analysis performed, this study compared exclusive use 
of DES with MIDCAB in 463 consecutive patients. After adjustment at 5-year follow-up 
there were no differences in survival, MACCE free survival and MI survival between PCI 
and MIDCAB respectively. However, there was a significantly higher freedom from 
repeated revascularization in patients who underwent MIDCAB [17].  
It was considered essential to underline that this report is different from most 
studies as it refers to long-term follow up after minimally invasive surgical 
revascularization. The majority of large-group observations, including the Holzhey analysis 
of more than 1300 patients, which represented mainly or exclusively cases of direct vision 
LITA harvest. This makes the present observation quite unique and results seem to be even 
more valuable. The direct vision LITA harvesting may be associated with the risk of 
kinking, not to mention the necessity of costal resection or tough chest wall retraction. 
Furthermore, the endoscopy allows a complete dissection of the LITA from the subclavian 
artery to the sixth intercostal branches with transection of all collateral branches originating 
from LITA. This result is difficult to acquire under direct vision. In consequence, mastering 
the endoscopic LITA harvest ensures the avoidance of possible coronary steal syndrome 
[18, 19]. Sabashnikov et al. [20] reported results of a team experienced in performing 
minimally invasive surgical revascularization in its various dimensions. They concluded 
that the endoscopic approach (EACAB) for LITA harvest is free from the disadvantages of 
longer operation duration observed in robotically assisted direct coronary artery bypass 
grafting (RADCAB) or higher incidence of angina and shorter freedom from MACEs 
observed in both MIDCAB and RADCAB groups [20]. This fact clearly demonstrates that 
both high quality anastomosis and perfect LITA harvest remain essential for satisfactory 
clinical outcome.  
 
Limitations of the study 
An inability to collect follow-up from approximately 25% of patients is a significant 
limitation of this research. However, the data obtained from the national registry database 
PESEL was crucial to the current study, as it allowed  gathering of 100% follow-up 
regarding overall mortality. Additionally, the utilized method of data collection does not 
provide absolute certainty on whether renewed revascularization targeted the previously 
treated vessel or one of other coronary arteries. This information is vital for the proper 
evaluation of MIDCAB efficacy and can only be achieved through thorough evaluation of 
follow-up angiograms. 
 
CONCLUSIONS 
The presented short and long-term results confirm that MIDCAB (EACAB) is an 
efficacious alternative for patients requiring revascularization of the left anterior 
descending artery. The method is highly beneficial for the patient as it eliminates the use of 
cardiopulmonary bypass and avoids the sternotomy, which are both related to a number of 
complications widely described in the literature. The frequency of MACCE is low and 
acceptable, similar to a general population. However, it is to be remembered that the proper 
selection of patients in terms of both surgical risk and anatomical setting of presented 
coronary artery lesions remains essential. 
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Table 1. Study cohort characterization. 
Variable Value 
Age [years] 57.9 ± 9.7 (57.0; 51–65) 
Body weight [kg] 74.6 ± 16.1 (75.5; 64.5–85) 
Height [m] 1.70 ± 0.08 (1.71; 1.64–1.76) 
BMI [kg/m²] 
Mean 27.6 ± 3.8 (27.6; 25.5–29.4) 
≥ 25 kg/m2 75.2% 
CCS class 
Mean 2.0 ± 0.37 (2.0; 2–2) 
1 6.8% 
2 86.1% 
3/4 7.1% 
NYHA class 
Mean 1.1 ± 0.27 (1.0; 1–1) 
I 91.8% 
II 8.2% 
III/IV – 
Arterial hypertension 51.5% 
Diabetes 13.9% 
MI in history 39.8% 
PCI in history 24.6% 
Dyslipidemia 57.4% 
Nicotinism 79% 
Renal insufficiency 1% 
Peptic ulcer disease in history 1.5% 
Peripheral artery disease 2% 
Stroke/TIA in history 0.8% 
Thyroid disease 1.8% 
COPD 2.8% 
EuroSCORE [points] 
Mean 1.88 ± 1.87 (2.0; 0–3) 
0–2 68.7% 
3–5 28.6% 
>5 2.7% 
Logistic EuroSCORE [%] 2.0 ±1.9 (1.33; 0.88–2.36) 
Ejection fraction [%] 
Mean 54.7 ± 7.4 (55; 50–60) 
> 50% 74.2% 
30–50% 25.6% 
< 30% 0.2% 
Valvular disease 
MVI +/++ 3% 
TVI +/++ 0.3% 
BMI — body mass index; CCS — Canadian Cardiovascular Society; COPD — chronic obstructive 
pulmonary disease; MI — myocardial infarction; NYHA — New York Heart Association; PCI — 
percutaneous coronary intervention; TIA — transient ischemic attack 
 
 
Table 2. Periprocedural complications (up to 30 days). 
Type of complication Frequency 
Death 0% 
Left ventricular insufficiency 0.1% 
Sudden cardiac arrest 0.6% 
Myocardial infarction 1.5% 
IABP 0.4% 
Inotropic support 
Aggregate 1,3% 
Epinephrine 0,3% 
Norepinephrine 1,0% 
Dopamine 1,0% 
Arrhythmias (AF/SVT) 3.6% 
Conduction disorders 0% 
Stroke/TIA 0.2% 
Acute kidney injury  0% 
Acute lower limb ischemia 0% 
Prolonged ventilation (> 48 h) 0.1% 
Reintubation 0.1% 
Gastrointestinal bleeding 0.1% 
Delirium 0.6% 
Multi organ failure  0.1% 
Systemic infection 0% 
Wound infection 1.6% 
Pleural effusion 7.0% 
Chest revision surgery 2.7% 
AF — atrial fibrillation; TIA — transient ischemic attack 
 
 
 
Table 3. Clinical profile changes. 
Variable 
Group 1 
(1998–2002) 
Group 2 
(2003–2005) 
Group 3 
(2006–2009) 
P 
Male sex 84.9% 74.5% 79.8% 0.15 
Age [years] 55.1 ± 9.6 58.5 ± 9.6 59.9 ± 9.2 0.001 
Body weight [kg] 71.9 ± 16.4 81.6 ± 14.1 79.8 ± 13.3 0.001 
Height [m] 1.72 ± 8.2 1.71 ± 8.4 1.7 ± 7.4 0.68 
BMI [kg/m²] 
 25.1 ± 4.1 27.8 ± 3.6 27.5 ± 4.1 0.51 
≥ 25 kg/m2 58% 79% 78% 0.42 
CCS class  1.98 ± 0.33 2.01 ± 0.41 2.02 ± 0.39 0.59 
1 6.5% 7.5% 6.5% 
0.57 2 88.8% 84.1% 85% 
3/4 4.7% 8.4% 8.5% 
NYHA class 
 1.04 ± 0.19 1.13 ± 0.34 1.08 ± 0.28 0.11 
I 96.2% 86.9% 91.6% 
0.05 
II 3.8% 13.1% 8.4% 
EuroSCORE 
[points] 
 1.11 ± 1.12 1.51 ± 1.69 2.11 ± 1.95 0.06 
0–2 72.5% 68.7% 64.2% 
0.03 3–5 26% 28.5% 32.5% 
> 5 1.5% 2.8% 3.3% 
Logistic EuroSCORE [%] 1.12 ± 0.75 1.53 ± 0.89 2.26 ± 2.24 0.06 
Ejection fraction 
[%] 
 55.8 ± 8.0 54.2 ± 6.6 54.2 ± 7.2 0.13 
> 50% 76.2% 73.8% 75.1% 
0.61 30–50% 23.7% 26% 24.7% 
< 30% 0.1% 0.2% 0.2% 
Valvular disease 
IVM +/++ 0 4.2% 5.8% 0.001 
IVT +/++ 0 0 1.3% 0.04 
Arterial hypertension 45.2% 49.5% 69% 0.001 
Diabetes 9.5% 14% 18.9% 0.005 
MI in history 35.3% 38.9% 44.9% 0.03 
PCI in history 11% 29.7% 33.1% 0.001 
Dyslipidemia 53% 62% 57.4% 0.32 
Nicotinism 75% 80% 78% 0.56 
Renal insufficiency 0.4% 0 2.4% 0.03 
Peptic ulcer disease in history 0 1.4% 3.4% 0.004 
Peripheral artery disease 2.2% 0 3.8% 0.24 
Stroke/TIA in history 0 0.4% 1.9% 0.02 
Thyroid disease 0.8% 1.4% 3.3% 0.05 
COPD 1.3% 4.2% 2.8% 0.21 
BMI — body mass index; CCS — Canadian Cardiovascular Society; COPD — chronic obstructive 
pulmonary disease; MI — myocardial infarction; NYHA — New York Heart Association; PCI — 
percutaneous coronary intervention; TIA — transient ischemic attack 
 
 
Table 4. Periprocedural complications (up to 30 days) with subgroup analysis. 
Type of complication 
Group 1 
(1998–2002) 
Group 2 
(2003–2005) 
Group 3 
(2006–2009) 
P* 
Mean 
aggregate 
Death 0 0 0 – 0% 
Left ventricular insufficiency 0.4% 0 0 0.21 0.1% 
Sudden cardiac arrest 1.7% 0 0 0.01 0.6% 
Myocardial infarction 4.2% 0.4% 0 0.001 1.5% 
IABP 0.4% 0 0 0.47 0.4% 
Inotropic support 
1.5% 0.8% 0.6% 0.11 0.11 1.3% 
0.4% 0 0 0.21 0.21 0.3% 
1.8% 0 0.8% 0.14 0.14 1.0% 
1.5% 1% 0 0.21 0.21 1.0% 
Arrhythmias (AF/SVT) 4.2% 3.1% 3.6% 0.74 3.6% 
Conduction disorders 0 0 0 – 0% 
Stroke/TIA 0 0 0.8% 0.09 0.2% 
Acute kidney injury 0 0 0 – 0% 
Acute lower limb ischemia 0 0 0 – 0% 
Prolonged ventilation (> 48 h) 0.4% 0 0 0.21 0.1% 
Reintubation 0 0 0.4% 0.21 0.1% 
Gastrointestinal bleeding 0.4% 0 0 0.21 0.1% 
Delirium 0.4% 0.9% 0.4% 0.97 0.6% 
Multi organ failure 0 0 0.4% 0.21 0.1% 
Systemic infection 0 0 0 – 0% 
Wound infection 1.7% 1.7% 1.2% 0.31 1.6% 
Pleural effusion 5.8% 7.5% 6% 0.94 7.0% 
Chest revision surgery 3.4% 3.5% 1.2% 0.14 2.7% 
AF — atrial fibrillation; TIA — transient ischemic attack 
 
 
 
Table 5. major adverse cerebral and cardio-vascular events (MACCE) risk factors analysis in very long-term 
observation.  
 MACCE Death MI  RE-PCI Stroke/TIA 
Male sex 
1.17 (0.62–2.16) 
p = 0.72 
0 (0–1.13) 
p = 0.15 
1.35 (0.37–4.55) 
p = 0.83 
1.42 (0.68–
2.91) 
p = 0.41 
3.33 (0.58–17.81) 
p = 0.24 
Age > 57 years 
1.72 (1.03–2.86) 
p = 0.02 
2.29 (0.88–
6.83) 
p = 0.08 
0.92 (0.32–2.62) 
p = 0.94 
1.47 (0.79–
2.73) 
p = 0.25 
6.30 (0.75–139) 
p = 0.05 
Ejection fraction < 50% 
3.03 (1.49–6.25) 
p = 0.001 
3.55 (1.03–
11.59) 
p = 0.03 
3.56 (1.49–20.6) 
p = 0.005 
0.49 (0.19–
1.31) 
p = 0.18 
3.76 (0.47–24.55) 
p = 0.10 
Diabetes 
1.45 (0.72–2.88) 
p = 0.34 
1.98 (0.53–
6.72) 
p = 0.40 
1.49 (0.33–5.70) 
p = 0.79 
1.32 (0.55–
3.07) 
p = 0.64 
1.0 (0.98–1.03) 
p = 0.69 
Arterial hypertension 1.05 (0.63–1.77) 1.02 (0.36– 1.31 (0.45–3.86) 0.79 (0.42– 4.60 (0.52–104) 
p = 0.95 2.95) 
p = 0.84 
p = 0.76 1.48) 
p = 0.52 
p = 0.12 
Incomplete 
revascularization 
3.30 (0.44–19.64) 
p = 0.37 
0 (0–32.03) 
p = 0.44 
6.58 (1–109.1) 
p = 0.05 
2.18 (0.80–
3.47) 
p = 0.46 
0 (0–107.67) 
p = 0.79 
PCI in history 
2.13 (1.28–3.54) 
p = 0.002 
2.15 (0.79–
5.82) 
p = 0.09 
2.70 (0.94–7.80) 
p = 0.06 
2.11 (1.14–
3.91) 
p = 0.01 
1.76 (0.31–9.38) 
p = 0.73 
MI in history 
0.89 (0.52–1.53) 
p = 0.76 
1.12 (0.38–
3.25) 
p = 0.98 
1.83 (0.64–5.28) 
p = 0.32 
0.73 (0.37–
1.44) 
p = 0.42 
0.32 (0.01–2.79) 
p = 0.49 
CCS class 3–4 vs. 1–2 
1.02 (0.34–2.83) 
p = 0.97 
1.0 (0.95–
1.05) 
p = 0.87 
1.0 (0.95–1.05) 
p = 0.87 
0.92 (0.22–
3.28) 
p = 0.86 
0 (0–13.14) 
p = 0.88 
NYHA class II vs. I 
2.63 (1.15–5.93) 
p = 0.01 
3.12 (0.88–
12.33) 
p = 0.08 
3.12 (0.88–12.33) 
p = 0.08 
1.32 (0.38–
4.12) 
p = 0.83 
0 (0–13.38) 
p = 0.87 
Urgent surgery 
0.47 (0.11–1.60) 
p = 0.28 
1.45 (0–6.82) 
p = 0.95 
0.99 (0.96–1.03) 
p = 0.84 
0 (0–2.13) 
p = 0.27 
0 (0–9.78) 
p = 0.96 
CCS — Canadian Cardiovascular Society; MI — myocardial infarction; NYHA — New York Heart 
Association; PCI — percutaneous coronary intervention; TIA — transient ischemic attack 
 
 
 
 
 
FIGURES LEGEND  
 
Figure 1. Kaplan-Mayer survival rate of 96.1%. 
 
Figure 2. Major adverse cerebral and cardio-vascular events (MACCE) — free survival of 
85.3%. 


